Ellen N. Spremulli

1.5k total citations
25 papers, 687 citations indexed

About

Ellen N. Spremulli is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ellen N. Spremulli has authored 25 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ellen N. Spremulli's work include Lung Cancer Research Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Ellen N. Spremulli is often cited by papers focused on Lung Cancer Research Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Ellen N. Spremulli collaborates with scholars based in United States and United Kingdom. Ellen N. Spremulli's co-authors include Daniel L. Dexter, Paul Calabresi, Zuzana Fligiel, J A Barbosa, Abby VanVoorhees, Elliot Alpert, Frank H. DeLand, Jon P. Gockerman, F. James Primus and David M. Goldenberg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The American Journal of Medicine.

In The Last Decade

Ellen N. Spremulli

25 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen N. Spremulli United States 14 258 255 172 144 126 25 687
C. J. Kovacs United States 18 194 0.8× 240 0.9× 81 0.5× 183 1.3× 133 1.1× 55 722
M. Satya Murthy United States 16 267 1.0× 273 1.1× 83 0.5× 131 0.9× 104 0.8× 36 726
J. Mills United Kingdom 11 290 1.1× 253 1.0× 172 1.0× 185 1.3× 100 0.8× 21 671
Linda Simpson‐Herren United States 15 288 1.1× 324 1.3× 158 0.9× 91 0.6× 123 1.0× 29 794
Eamonn P. Dunphy United States 12 365 1.4× 220 0.9× 205 1.2× 142 1.0× 172 1.4× 18 799
Carl G. Schmidt Germany 13 265 1.0× 349 1.4× 81 0.5× 75 0.5× 84 0.7× 33 798
B Soehnlen United States 11 513 2.0× 582 2.3× 188 1.1× 120 0.8× 139 1.1× 15 1.2k
R Silvestrini Italy 14 558 2.2× 507 2.0× 252 1.5× 72 0.5× 101 0.8× 29 969
E Niskanen United States 15 490 1.9× 480 1.9× 182 1.1× 97 0.7× 72 0.6× 49 1.0k
Sigrid Lönn Sweden 16 338 1.3× 479 1.9× 150 0.9× 68 0.5× 58 0.5× 43 729

Countries citing papers authored by Ellen N. Spremulli

Since Specialization
Citations

This map shows the geographic impact of Ellen N. Spremulli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen N. Spremulli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen N. Spremulli more than expected).

Fields of papers citing papers by Ellen N. Spremulli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen N. Spremulli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen N. Spremulli. The network helps show where Ellen N. Spremulli may publish in the future.

Co-authorship network of co-authors of Ellen N. Spremulli

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen N. Spremulli. A scholar is included among the top collaborators of Ellen N. Spremulli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen N. Spremulli. Ellen N. Spremulli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greco, F. Anthony, Dana S. Thompson, Lisa H. Morrissey, et al.. (2005). Paclitaxel/Carboplatin/Etoposide Versus Paclitaxel/Topotecan for Extensive-Stage Small Cell Lung Cancer: A Minnie Pearl Cancer Research Network Randomized, Prospective Phase II Trial. The Oncologist. 10(9). 728–733. 12 indexed citations
2.
Thompson, Dana S., John D. Hainsworth, Lisa H. Morrissey, et al.. (2004). Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive stage small cell lung cancer: A Minnie Pearl Cancer Research Network randomized prospective phase II trial. Journal of Clinical Oncology. 22(14_suppl). 7205–7205. 1 indexed citations
3.
Cummings, F J, Gerald W. Crabtree, Michael C. Wiemann, et al.. (1988). Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin. Clinical Pharmacology & Therapeutics. 44(5). 501–509. 7 indexed citations
4.
Wiemann, Michael C., Gerald W. Crabtree, Alan B. Weitberg, et al.. (1988). Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil. Medical Oncology and Tumor Pharmacotherapy. 5(2). 113–116. 2 indexed citations
5.
Spremulli, Ellen N., et al.. (1984). Tissue Analysis of N-Methylformamide: Organ Distribution. Journal of Analytical Toxicology. 8(3). 146–148. 1 indexed citations
6.
Spremulli, Ellen N. & Daniel L. Dexter. (1984). Polar solvents: a novel class of antineoplastic agents.. Journal of Clinical Oncology. 2(3). 227–241. 89 indexed citations
7.
Spremulli, Ellen N., John T. Leith, D. Campbell, et al.. (1983). Response of a human colon adenocarcinoma (DLD-1) to X irradiation and mitomycin C in vivo. International Journal of Radiation Oncology*Biology*Physics. 9(8). 1209–1212. 14 indexed citations
8.
Spremulli, Ellen N. & Daniel L. Dexter. (1983). Human tumor cell heterogeneity and metastasis.. Journal of Clinical Oncology. 1(8). 496–509. 81 indexed citations
9.
Spremulli, Ellen N., H A Bogaars, Daniel L. Dexter, et al.. (1983). Nude mouse model of the melanosis syndrome.. PubMed. 71(5). 933–9. 5 indexed citations
10.
Dexter, Daniel L., et al.. (1983). A Therapeutic Monitoring Assay for N-Methylformamide in Human Serum and Urine. Journal of Analytical Toxicology. 7(2). 89–91. 2 indexed citations
11.
Spremulli, Ellen N., D. Campbell, N. Peter Libbey, et al.. (1983). Characterization of two metastatic subpopulations originating from a single human colon carcinoma.. PubMed. 43(8). 3828–35. 23 indexed citations
12.
Spremulli, Ellen N., et al.. (1982). A phase II study of Nolvadex® tamoxifen citrate in the treatment of advanced prostatic adenocarcinoma. American Journal of Clinical Oncology. 5(2). 149–154. 21 indexed citations
13.
Dexter, Daniel L., et al.. (1982). Inhibition of the growth of human colon cancer xenografts by polar solvents.. PubMed. 42(12). 5018–22. 46 indexed citations
14.
Wiemann, Michael C., et al.. (1982). Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.. PubMed. 42(9). 3896–900. 2 indexed citations
15.
Dexter, Daniel L., Ellen N. Spremulli, Zuzana Fligiel, et al.. (1981). Heterogeneity of cancer cells from a single human colon carcinoma. The American Journal of Medicine. 71(6). 949–956. 139 indexed citations
16.
Goldenberg, David M., Frank H. DeLand, Ellen N. Spremulli, et al.. (1980). Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. Cancer. 45(10). 2500–2505. 98 indexed citations
17.
Spremulli, Ellen N., et al.. (1980). Phase II study of VM-26 in adult malignancies.. PubMed. 64(1). 147–9. 20 indexed citations
18.
Casper, Scott E., et al.. (1979). Axillary lymphoscintigraphy by radioimmunodetection of carcinoembryonic antigen in breast cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(12). 1243–50. 50 indexed citations
19.
Spremulli, Ellen N., Galen L. Wampler, & William Regelson. (1979). Clinical study of hydrazine sulfate in advanced cancer patients. Cancer Chemotherapy and Pharmacology. 3(2). 121–4. 18 indexed citations
20.
Spremulli, Ellen N., Galen L. Wampler, William Regelson, Dennis Borochovitz, & Thomas G. Hardy. (1977). Chemotherapy of malignant mesothelioma. Cancer. 40(5). 2038–2045. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. J. Kovacs Breakdown of academic impact, for papers by M. Satya Murthy Breakdown of academic impact, for papers by J. Mills Breakdown of academic impact, for papers by Linda Simpson‐Herren Breakdown of academic impact, for papers by Eamonn P. Dunphy Breakdown of academic impact, for papers by Carl G. Schmidt Breakdown of academic impact, for papers by B Soehnlen Breakdown of academic impact, for papers by R Silvestrini Breakdown of academic impact, for papers by E Niskanen Breakdown of academic impact, for papers by Sigrid Lönn
Rankless by CCL
2026